pharmacopoeias have become available outside the countries of their origin. This spread, and the growing importance of global standards of safety in medicine, have led to increased public discussion of both the safety and the efficacy of Asian medicines containing mercury. Both European and Asian historical sources dating from the premodern period show that in the past, doctors and patients alike were aware of the dangerous effects of mercury. However, symptoms of mercury poisoning such as salivation, tooth decay and ulcers in the mouth were mostly interpreted as either proof of the efficacy of the treatment, or as regrettable side effects that could be balanced with countermeasures. But modern scientific research on the effects of mercury on human health is unequivocal in stating that mercury is toxic to humans. Accordingly, the 2013 Minamata Convention on Mercury -an international treaty that addresses the problems associated with mercury pollution -scheduled a global ban on mercury products, to be phased in over a period of time, that included mercury compounds in human pharmaceutical drug products. 1 The Convention condones some exemptions, such as products used in religious or traditional rites, which may include traditional medical uses of mercury. Nevertheless, the enactment of the treaty by regulatory bodies is likely to have serious implications for the trade in traditional Asian medicines and the practice of Asian medical systems.
Responses from stakeholders in Asian medical systems have been varied, and range from acknowledging the use of mercury in medicine as problematic, to arguing for more substantial scientific testing of the contested medicines instead of their wholesale rejection, to impassioned calls to defend mercurial medicines as integral and time-tested elements of their medical tradition.
Contemporary proponents of mercury medicines argue that if their traditional procedures for purifying and detoxifying mercury are followed carefully, mercury medicines are not only completely safe for human use, but offer the most powerful cures. Their perspective, however, is often countered with heavy criticism and stories of poisoning through medicines containing mercury and other heavy metals. In a recent issue of the German mass-circulation magazine Der Spiegel, 2 an article entitled "Pillen aus der Hexenküche" ("pills from the witches' kitchen") reported the case of a female patient in Germany, who had been admitted to a hospital in Hamburg with severe symptoms of poisoning. The patient had developed these symptoms after a week of treatments in an ayurvedic clinic in Sri Lanka and a subsequent course of ayurvedic medicines given to her at the clinic, which she had taken over several weeks at home. An analysis of the pills revealed extremely high levels of mercury and lead, the amounts of mercury apparently being 566110 times higher than levels considered safe for consumption. The doctor's conclusion was that the patient's intake of mercury and lead could have killed her and very nearly did. The article was unequivocal in its critique of the use of heavy metals in ayurvedic drug formulations, using the fact of their use in this medicine as an indictment against the "witches' kitchen" of Ayurveda as a whole. The reader is left in no doubt that the intake of medicines that contain mercury will inevitably lead to serious, perhaps even irrevocable damage.
The tension between a long-established use of mercury in medicine and modern research on the deleterious effects of mercury on human health makes an inquiry into the beginnings of the use of mercury in medicine particularly topical. If mercury has always been known to be poisonous, why did different medical systems develop reasons for using mercurial medicines and methods for preparing them?
The articles in this issue examine the history of the uses of mercury in a number of medical traditions from the medieval period to the present. Drawing upon the primary textual sources of each respective tradition -European, South Asian, Chinese, Tibetan, Japanese, Arabic and Persian -the authors explore the epistemologies of the use of mercury in medicine. Why, when and how was mercury used in the different medical traditions, and why does it sometimes continue to be used?
The research presented here is part of an ongoing conversation between a group of scholars from a range of backgrounds, including anthropology, Tibetan studies, South Asian studies, neurology, and history and medical practitioners in Tibetan and traditional Chinese medicine that began at the Humboldt University in Berlin in 2012 with the symposium "Mercury -Elixir of Life or Poison? Purification of toxic substances in medical systems in Europe and Asia". This meeting was convened by Barbara Gerke, who invited participants to reflect on how different medical traditions understand the characteristics of mercury and deal with the issue of its toxicity.
3 Several of the papers presented at the symposium were published in the special issue Mercury in Ayurveda and Tibetan Medicine of the journal Asian Medicine -Tradition and Modernity. 4 This is recommended reading particularly for those interested in the use of mercury in the Tibetan and ayurvedic medical traditions. In order to deepen the discussion begun in Berlin, I convened a further meeting at Zurich university in February 2013. Entitled "Mercury in medicine: fluid economies of knowledge and trade", it allowed participants to develop the group's previous research. 5 The field of enquiry was broadened to encompass the history of mercury therapies in Chinese and Burmese medicine, as well as in works written in Arabic or Persian, i.e., works belonging to the so-called GraecoArabic or Islamic medical tradition.
6
The present volume is based on the presentations and discussions at the Zurich meeting. Regrettably, not all contributions of the scholars present at the workshop are represented here. The work of two scholars who did not attend has been added: Claudia Preckel on Unani medicine and Brigitte Sébastia on Siddha medicine and alchemy. It is to be hoped that the research not included here will become available in due course. Ulrike Unschuld gave an excellent introduction to the history of the medical use of mercury in China. Andrew Cunningham offered a valuable exploration of the inner-European medical trade of mercury, focussing on the production of mercury at the Almadén mines. He is currently working on a monograph on the history of mercury in European medicine that will complement the more Asia-focussed research in this issue. Following up on questions that had arisen at his presentation in Berlin, Jürgen Aschoff spoke about modern research on the safety and efficacy of mercury in traditional Asian medicine, noting the dearth of relevant data and the lack of serious scientific research in this field. Some of his conclusions can be found in his article in Asian Medicine 8.1.
7 And finally, Ian Baker presented the use of mercury by modern-day alchemists in Burma (Myanmar) whose mercury-based practices seem both vibrant and surprisingly well-known to the populace at large. Burmese alchemy is practised both in Buddhist monasteries and in lay settings and centres on the forging of amalgamated mercuric dhatlon, or "essence balls". These are derived from liquid mercury and are used medicinally, but are also ascribed with the power to give consumers siddhis, or special abilities. Although heavily influenced by Buddhist tantric ideas, these practices also seem closely related to those of Tamil Siddha practitioners, as described by Brigitte Sébastia in this volume. The connections between these traditions would constitute a fascinating research area, and further study of either tradition's literary past and present practice are very much a desideratum. 9 Happily, plans for a research project focussing on Tamil Siddha iatrochemical literature are underway at the French Institute of Pondicherry and should add to our understanding of this tradition. Several articles in this issue present processing methods, recipes and applications of mercury medicines and their development over time, and also seek to identify and trace connections in medical theory and techniques with other medical traditions. Some of these connections between medical cultures are fairly well known, such as the trajectory from Greek medicine to Arabic and Persian medicine and thence to Unani medicine. Or indeed from Greek to Arabic to European (works in Latin) and back to Arabic medicine, as Natalia Bachour 7 See Aschoff 2013. 8 A recording of Baker's presentation can be viewed at https://youtu.be/GYkuHKt13as (last viewed 21.09.2015). 9 There is an excellent study of the Siddha medical tradition in its modern and politicized incarnations by R. Weiss (2009) , as well as a number of articles by various scholars. These, however, do not primarily deal with the contents of Siddha medical literature, much of which is to date only extant in manuscript form. On Burmese alchemical cults, see Brac de la Perrière et al. 2014. shows in this volume. Here, links can be traced through literature, as medical authors translated and commented on older literature, developing new practices on the basis of older ones. However, even in traditions that are connected in this way, certain key moments in which mercurial practices appear cannot be fully explained as a continuation of earlier practices. This is partly due to the limited number of sources we were able to consult for our research and the general focus on medical, rather than alchemical texts, but also partly due to some sources not being available or perhaps simply not known at present.
Therefore, there are a number of missing links in our reconstruction of how concepts concerning mercury were shared or transferred. Some of these can be guessed at: There are certain clues, sometimes even clear statements in the Editorial textual sources about the provenance of recipes, methods of preparation, applications and sourcing of ingredients. However, often these hints or statements present us with further puzzles. For example, one Persian author, discussed by Thomann in this volume, attributes some of his antisyphilitic recipes to Indian sources, others to Chinese ones and yet others to European ones. However, a comparison with recipes in the surviving Indian medical sources does not bring up corresponding formulations. In turn, the Sanskrit medical texts use loanwords from the Persian in the relevant sections and there is also a certain overlap in the use of ingredients, which seems to point to Persia or authors writing in Persian as the source of the new formulations (see my article in this volume). Bachour suggests that the sudden appearance of mercury medicines in Arabic medical literature may go back to contact with Indian physicians and also the translation projects of the ninth century, when certain Indian medical works were translated or paraphrased into Arabic (in some cases via Persian translations). The problem here is that the works known to have been used for these translations predate the widespread use of mercury and particularly the associated practices of processing mercury in Indian medicine. 10 The answer may lie in currently undiscovered or unstudied texts: much remains to be done in the textual study of Sanskrit, but also Arabic and Persian medical texts. Answers may also be found in alchemical, rather than medical sources. David White notes that "nearly all the mercury the Indian alchemists would later use came from China: given the fact that there exist no mercurial deposits on the subcontinent, China was India's nearest and most obvious supplier." 11 White summarizes the Sino-Indian points of contact as follows: "(1) the mountain passes located in the northwestern region of the subcontinent (Himalayan Pakistan and Afghanistan) and (2) Assam to the east -these being the two regions through which the Indian spurs of the Silk Road passed -as well as (3) the major seaports on the coastlines of Tamil Nadu and Gujarat, which linked India to China and the west (… some drugs from China arrived in India with Persian names. 14 For example, China root was known as cobacīnī in India, a Sanskritized form of the Persian chub-i-chini. This root was used in antisyphilitic therapies in Persia, India and China and was also associated with alleviating the side effects of mercury therapy. One can easily imagine not only medicinal goods, but also alchemical and medical ideas being transported along the trade routes, being adapted and developed along the way as traders encountered both different substances and other modalities of alchemical and medical thought as well as the pressure to sell their wares. Finally, one should also not discount another possibility, namely the absorption of popular medical practices into scholarly medicine. Bachour mentions a relevant citation from the seventh-century Byzantine physician Paul of Aegina that states:
It [i.e. mercury] is rarely used for medical purposes because of its lethal effect. Some people burn it until it becomes like ash, mix it with other substances and give it as beverage to the sufferers from colic and the so-called ileus.
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While Paul of Aegina advised against the medicinal use of mercury, the dust of mercury mentioned by him later appears in Arabic medical works, al-Ṭabarī's Firdaws al-ḥikma fī l-ṭibb (The paradise of wisdom in medicine) being an early example, as Bachour shows. This seems to suggest that practices that had previously been rejected by medical scholars found their way into scholarly medicine eventually. What remains unexplained is the process which allowed this to happen. What changed scholar-physicians' minds? Daniel Trambaiolo's article in this volume describes how Chinese alchemical and medical practices involving mercury, which had been developed at a much earlier period than the other medical traditions explored in this volume, became less and less popular in the Tang (618-907) and Song (960-1279) periods. Strikingly, this decline in the use of mercurials coincided with the appearance of and then growing importance of mercurials in medicine in South and Central Asia. However, the medicinal use of mercury went through a renaissance in sixteenth-century China, due to the arrival of a new disease, which was considered particularly terrible and which challenged doctors to experiment with new forms of therapy, as Trambaiolo argues. It seems likely that this new disease was syphilis. 16 Several of the articles in this volume (those by Bachour, Thomann, Trambaiolo, Preckel and myself) discuss how the arrival of this new disease impacted on medical practices. Mercury played a particularly important role in the treatment of this disease throughout Asia, just as it did in Europe. And it is in this context that transfers of knowledge between the various medical traditions seem particularly likely, though the articles in this issue reveal significant differences in approaches to treatment as well.
The relationship of Japanese medicine with Chinese medical sources is fairly straightforward: Trambaiolo gives examples of how Japanese medical authors made use of recipes of Chinese authors, in particular for making mercury chloride compounds. He argues that the familiarity with Chinese formula for making these compounds paved the way for the later reception of European style mercury chloride drugs. Mercury compounds had been produced in Japan since at least the eighth century, using mercury and cinnabar from Japanese sources, particularly from the cinnabar mines around Ise. However, when the mines around Ise became exhausted in around the eighteenth century, supplies of mercury were obtained through Chinese or Dutch merchants. And it is in this period that Dutch procedures for making sublimated mercury compounds made their way into Japanese medicine. However, these were considered to result in quite separate products with significant functional difference from the mercury chlorides made following Chinese recipes. And while Japanese doctors found ways of using mercury chlorides produced according to European methods, it seems these did not include administering them according to Dutch or European prescriptions. The Dutch had the monopoly in making and trading mercury compounds (corrosive sublimate and calomel) in eighteenth-century Europe. However, the Swiss physician and chemist Christoph Girtanner warned of the bad quality of the Dutch products, claiming that their sublimates were often adulterated with arsenic and suggesting methods for recognizing and countering adulterations.
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16 The identification of historical disease categories is always problematic and the use of the term "syphilis" is used as a "pragmatic translation for a group of related terms" (Trambaiolo in this volume). Given that microorganisms as causative factors for diseases were not known until the nineteenth century and that the bacterium that causes syphilis, treponema pallidum, was only identified in 1905, we cannot know whether the disease described in older historical sources in fact describe syphilis as we understand it today. However, skeletal evidence shows syphilis to have been common in Asian countries. 17 Girtanner 1797: 324-331. Timothy Walker's article in this volume shows how Jesuits, using the new global networks of trade that emerged with the sixteenth-century discovery of the New World, formulated new medicines that contained substances from all parts of the Portuguese imperial world. The Portuguese use of mercury depended almost exclusively on commerce with imperial Spain and its mercury in the mines of Almadén, 18 as neither Portugal itself, nor its territories, produced appreciable amounts of mercury, as Walker points out. However, mercuryoften combined with exotic substances from the colonies -was nevertheless a staple ingredient in many Jesuit formulations. Three papers in this volume deal with continuing practices of using mercury: Claudia Preckel's article describes the continuation and development of practices first found in Arabic and Persian sources in Unani medicine, examining Unani sources from the fifteenth century to the present. As mentioned, Brigitte Sébastia discusses the role of mercurials for Siddha medicine, questioning the prominent position mercurials take in representations of this medical tradition. Her paper also explores the discourses surrounding the toxicity of mercury and the responses of modern practitioners of Siddha to research publications by biomedical scholars and the public reaction to them. Finally, the article by Barbara Gerke in this volume discusses the more recent history of the transmission of mercurial practices in Tibetan medicine. Tibetan medical practices were strongly influenced by the Chinese take-over of Tibet in the 1950s, and the following Cultural Revolution (1966) (1967) (1968) (1969) (1970) (1971) (1972) (1973) (1974) (1975) (1976) . As Gerke shows, these events affected the opportunities to transmit the knowledge and practice of making certain mercury compounds called tsotel. Her paper traces the personal histories of two Tibetan physicians, Tenzin Chödrak (1924 -2001 ) and Troru Tsenam (1926 -2004 and their role in the transmission of the tsotel practice, revealing how existing practices of making tsotel in India and the PRC are directly linked to these physicians.
The papers in this special issue of Asiatische Studien/Études Asiatiques cover much previously unexplored ground in the history of the use of mercury in medicine. However, further study and translations of medical and alchemical texts are needed to complement if not complete our picture of how mercury was 18 Arguably, the dependance on the Spanish extended to various groups of bankers. The mines of Almadén were controlled by the Fuggers from 1524 to 1645. The Fuggers were given a lease on the mines by Charles V, to pay for a loan he had taken in order to be elected from King of Spain to Holy Roman Emperor. See Goldwater 1972: 62-63 . Other banking houses implicated in the control of the mercury trade (through both the Almadén and Idria mines) included not only the Fuggers, but also Bartholomew Belser, the Hochstetters, the banking firm of Dentz and the Rothschilds. See Goldwater 1972: 66-71. Editorial 
